journal
MENU ▼
Read by QxMD icon Read
search

Gut Microbes

journal
https://www.readbyqxmd.com/read/28622070/loop-ileostomy-mediated-fecal-stream-diversion-is-associated-with-microbial-dysbiosis
#1
Emma L Beamish, Judith Johnson, Elisabeth J Shaw, Nigel A Scott, Arnab Bhowmick, Rachael J Rigby
Loop ileostomy is an effective procedure to protect downstream intestinal anastomoses. Ileostomy reversal surgery is often carried out within 12 months of formation but is associated with substantial morbidity due to severe post-operative complications. Distal ileum is deprived of enteral nutrition and rendered inactive, often becoming atrophied and fibrotic. This study aimed to investigate the microbial and morphological changes that occur in the defunctioned ileum following loop ileostomy-mediated faecal stream diversion...
June 16, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28598765/shigella-depends-on-sepa-to-destabilize-the-intestinal-epithelial-integrity-via-cofilin-activation
#2
Ana Maldonado-Contreras, James R Birtley, Erik Boll, Yun Zhao, Karen L Mumy, Juan Toscano, Seyoum Ayehunie, Hans-Christian Reinecker, Lawrence J Stern, Beth A McCormick
Shigella is unique among enteric pathogens, as it invades colonic epithelia through the basolateral pole. Therefore, it has evolved the ability to breach the intestinal epithelial barrier to deploy an arsenal of effector proteins, which permits bacterial invasion and leads to a severe inflammatory response. However, the mechanisms used by Shigella to regulate epithelial barrier permeability remain unknown. To address this question, we used both an intestinal polarized model and a human ex-vivo model to further characterize the early events of host-bacteria interactions...
June 9, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28586297/fecal-microbiota-variation-across-the-lifespan-of%C3%A2-the%C3%A2-healthy%C3%A2-laboratory-rat
#3
Burkhardt Flemer, Nadia Gaci, Guillaume Borrel, Ian R Sanderson, Prem P Chaudhary, William Tottey, Paul W O'Toole, Jean-François Brugere
Laboratory rats are commonly used in life science research as a model for human biology and disease, but the composition and development of their gut microbiota during life is poorly understood. We determined the faecal microbiota composition of healthy Sprague Dawley laboratory rats from 3 weeks to 2 years of age, kept under controlled environmental and dietary conditions. Additionally, we determined faecal short-chain fatty acid profiles, and we compared the rat faecal microbiota with that of mice and humans...
June 6, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28586253/characterization-of-recombinant-trypanosoma-brucei-gambiense-translationally-controlled-tumor-protein-rtbgtctp-and-its-interaction-with-glossina-midgut-bacteria
#4
Géraldine Bossard, Manon Bartoli, Marie-Laure Fardeau, Philippe Hozmuller, Bernard Ollivier, Anne Geiger
In humans, sleeping sickness (i.e. Human African Trypanosomiasis) is caused by the protozoan parasites Trypanosoma brucei gambiense (Tbg) in West and Central Africa, and T. b. rhodesiense in East Africa. We previously showed in vitro that Tbg is able to excrete/secrete a large number of proteins, including Translationally Controlled Tumour Protein (TCTP). Moreover, the tctp gene was previously described to be expressed in Tbg-infected flies. Aside from its involvement in diverse cellular processes, we have investigated a possible alternative role within the interactions occurring between the trypanosome parasite, its tsetse fly vector, and the associated midgut bacteria...
June 6, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28541799/limited-engraftment-of-donor-microbiome-via-one-time-fecal-microbial-transplantation-in-treated-hiv-infected-individuals
#5
Ivan Vujkovic-Cvijin, Rachel L Rutishauser, Montha Pao, Peter W Hunt, Susan V Lynch, Joseph M McCune, Ma Somsouk
BACKGROUND: Many HIV-infected individuals on antiretroviral therapy (ART) exhibit persistent systemic inflammation, which predicts morbidity and mortality. ART-treated subjects concurrently exhibit marked compositional alterations in the gut bacterial microbiota and the degree of dysbiosis correlates with systemic inflammation. Whether interventions to modulate the microbiome can affect systemic inflammation is unknown. METHODS: An open-label fecal microbial transplantation (FMT) was delivered by colonoscopy to asymptomatic HIV-infected ART-suppressed individuals without antibiotic pre-treatment...
May 25, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28541767/gas-filled-microbubbles-novel-mucosal-antigen-delivery-system-for-induction-of-anti-pathogen-s-immune-responses-in-the-gut
#6
Blaise Corthésy, Gilles Bioley
Despite important success in protecting individuals against many pathogenic infections, parenteral vaccination is not optimal to induce immunity at the site of pathogen entry, i.e. mucosal surfaces. Moreover, designing adequate delivery systems and safe adjuvants to overcome the inherent tolerogenic environment of the mucosal tissue is challenging, in particular in the gastrointestinal tract prone to antigen degradation. We recently demonstrated that intranasal administration of a Salmonella-derived antigen associated with gas-filled microbubbles induced specific Ab and T cell responses in the gut and was associated with a reduction in local and systemic bacterial load after oral Salmonella infection...
May 25, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28453386/collateral-damage-during-antibiotic-treatment-of-c-difficile-infection-in-the-aged-host-insights-into-why-recurrent-disease-happens
#7
Jae Hyun Shin, Cirle A Warren
Clostridium difficile infection (CDI) is one of the most common causes of healthcare-associated infections but an even bigger problem for the aging population. Advanced age leads to higher incidence, higher mortality, and higher recurrences. In our study, recently published in the Journal of Infectious Diseases, we investigated the effect of aging on CDI using a mouse model. We were able to demonstrate that aging leads to worse clinical outcomes, as well as lead to changes in microbiota composition and lower antibody production against C...
April 28, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28418756/cultured-microbes-represent-a-substantial-fraction-of-the-human-and-mouse-gut-microbiota
#8
Ilias Lagkouvardos, Jörg Overmann, Thomas Clavel
During the last 15 years, molecular techniques have been preferred over culture-based approaches for the study of mammalian gut microbiota, i.e. the communities of microorganisms dwelling in the intestine of mammals. The main reason is the belief that the majority of gut bacteria, especially strict anaerobes, escape cultivation. Despite numerous such statements in publications, the literature does not provide a clear overview on the subject. In the present manuscript, we highlight recent work on the cultivation of bacteria from the intestine of mammals, review the literature and provide novel data pertaining to cultured fractions of mammalian gut microbiota...
April 18, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28384049/intestinal-iga-as-a-modulator-of-the-gut-microbiota
#9
Shinsaku Okai, Fumihito Usui, Misa Ohta, Hiroshi Mori, Ken Kurokawa, Satoshi Matsumoto, Tamotsu Kato, Eiji Miyauchi, Hiroshi Ohno, Reiko Shinkura
Accumulating evidence suggests that dysbiosis plays a role in the pathogenesis of intestinal diseases including inflammatory bowel disease (IBD) as well as extra-intestinal disorders. As a modulator of the intestinal microbiota, we isolated a mouse monoclonal IgA antibody (clone W27) with high affinities for multiple commensal bacteria, but not for beneficial bacteria such as Lactobacillus casei (L. casei). Via specific recognition of an epitope in serine hydroxymethyltransferase (SHMT), a bacterial metabolic enzyme, W27 IgA selectively inhibited the in vitro growth of bound bacteria, including Escherichia coli (E...
April 6, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28609252/fecal-microbiota-transplantation-in-metabolic-syndrome-history-present-and-future
#10
P F de Groot, M N Frissen, N C de Clercq, M Nieuwdorp
The history of fecal microbiota transplantation (FMT) dates back even to ancient China. Recently, scientific studies have been looking into FMT as a promising treatment of various diseases, while in the process teaching us about the interaction between the human host and its resident microbial communities. Current research focuses mainly on Clostridium difficile infections, however interest is rising in other areas such as inflammatory bowel disease (IBD) and the metabolic syndrome. With regard to the latter, the intestinal microbiota might be causally related to the progression of insulin resistance and diabetes...
May 4, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28609251/intestinal-microbiota-fecal-microbiota-transplantation-and-inflammatory-bowel-disease
#11
Alexa R Weingarden, Byron P Vaughn
Inflammatory bowel disease (IBD) is a complex set of diseases that lead to chronic inflammation in the gastrointestinal tract. Although the etiology of IBD is not fully understood, it is well-known that the intestinal microbiota is associated with the development and maintenance of IBD. Manipulation of the gut microbiota, therefore, may represent a target for IBD therapy. Fecal microbiota transplantation (FMT), where fecal microbiota from a healthy donor is transplanted into a patient's GI tract, is already a successful therapy for Clostridium difficile infection...
May 4, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28394706/fecal-microbiota-transplantation-early-steps-on-a-long-journey-ahead
#12
Alexander Khoruts
No abstract text is available yet for this article.
May 4, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28318396/a-proposed-definition-of-microbiota-transplantation-for-regulatory-purposes
#13
Diane E Hoffmann, Francis B Palumbo, Jacques Ravel, Virginia Rowthorn, Erik von Rosenvinge
The advent of fecal microbiota transplantation (FMT) and the prospect of other types of microbiota transplants (MT), e.g. vaginal, skin, oral and nasal, are challenging regulatory agencies. Although FDA is regulating FMT (as a biologic), there is currently no widely accepted or agreed upon scientific or legal definition of FMT or MT. The authors report on discussions regarding a definition of MT that took place among a working group of stakeholders convened under a National Institutes for Allergies and Infectious Diseases grant to address the regulation of MT...
May 4, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28282270/community-dynamics-drive-punctuated-engraftment-of-the-fecal-microbiome-following-transplantation-using-freeze-dried-encapsulated-fecal-microbiota
#14
Christopher Staley, Byron P Vaughn, Carolyn T Graiziger, Stephanie Singroy, Matthew J Hamilton, Dan Yao, Chi Chen, Alexander Khoruts, Michael J Sadowsky
Fecal microbiota transplantation (FMT) is a highly effective treatment of recurrent and recalcitrant Clostridium difficile infection (rCDI). In a recent study oral-delivery of encapsulated, freeze-dried donor material, resulted in comparable rates of cure to colonoscopic approaches. Here we characterize shifts in the fecal bacterial community structure of patients treated for rCDI using encapsulated donor material. Prior to FMT, patient fecal samples showed declines in diversity and abundance of Firmicutes and Bacteroidetes, with concurrent increases in members of the Proteobacteria, specifically Enterobacteriaceae...
May 4, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28129018/challenges-in-fecal-donor-selection-and-screening-for-fecal-microbiota-transplantation-a-review
#15
Michael H Woodworth, Cynthia Carpentieri, Kaitlin L Sitchenko, Colleen S Kraft
Fecal microbiota transplantation is best understood as an effective and inexpensive therapy for recurrent Clostridium difficile infection but fecal donor selection and screening should be periodically revised. Here, we review current recommendations for selection and screening of fecal donors for fecal microbiota transplantation. We recommend considering diabetes mellitus, prior cardiovascular events, and clinical healthcare exposure as fecal donor exclusion criteria until more is known about the association of these conditions with the human gut microbiome...
May 4, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28103145/can-you-cause-inflammatory-bowel-disease-with-fecal-transplantation-a-31-patient-case-series-of-fecal-transplantation-using-stool-from-a-donor-who-later-developed-crohn-s-disease
#16
Monika Fischer, Mohamad Bittar, Eliseo Papa, Zain Kassam, Mark Smith
No abstract text is available yet for this article.
May 4, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28102756/treatment-of-recurrent-clostridium-difficile-infection-using-fecal-microbiota-transplantation-in-patients-with-inflammatory-bowel-disease
#17
Krista M Newman, Kevin M Rank, Byron P Vaughn, Alexander Khoruts
We recently compared results of fecal microbiota transplantation (FMT) in patients with refractory, recurrent Clostridium difficile infection (rCDI), with and without underlying inflammatory bowel disease (IBD). Here we extend this cohort and analyze outcomes in greater detail by subtype of IBD. We find that FMT is generally effective in breaking the cycle of CDI recurrence, but its effects on overall IBD progression are much less predictable. We discuss several challenges intrinsic to this complex clinical situation and outline the next steps that can address these challenges going forward...
May 4, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28059612/fecal-microbial-transplantation-as-a-therapeutic-option-in-patients-colonized-with-antibiotic-resistant-organisms
#18
Michael Laffin, Braden Millan, Karen L Madsen
Despite increasing interest in fecal microbiota transplantation (FMT), its full therapeutic potential has yet to be determined. Since its increase in popularity, FMT has been shown to be highly effective in the treatment of both Clostridium difficile infection (CDI) and its recurrent form. Interest in FMT now expands well beyond the treatment of CDI to other processes with known associations to the microbiota such as antibiotic resistant infections, inflammatory bowel disease (IBD), hepatic encephalopathy, neuropsychiatric disorders, and metabolic disease...
May 4, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28051919/analysis-of-gut-microbiota-an-ever-changing-landscape
#19
Michael J Sadowsky, Christopher Staley, Cheryl Heiner, Richard Hall, Colleen R Kelly, Lawrence Brandt, Alexander Khoruts
In the last two decades, the field of metagenomics has greatly expanded due to improvement in sequencing technologies allowing for a more comprehensive characterization of microbial communities. The use of these technologies has led to an unprecedented understanding of human, animal, and environmental microbiomes and have shown that the gut microbiota are comparable to an organ that is intrinsically linked with a variety of diseases. Characterization of microbial communities using next-generation sequencing-by-synthesis approaches have revealed important shifts in microbiota associated with debilitating diseases such as Clostridium difficile infection...
May 4, 2017: Gut Microbes
https://www.readbyqxmd.com/read/28001467/fecal-microbiota-transplant-in-severe-and-severe-complicated-clostridium-difficile-a-promising-treatment-approach
#20
Monika Fischer, Brian Sipe, Yao-Wen Cheng, Emmalee Phelps, Nicholas Rogers, Sashidhar Sagi, Matthew Bohm, Huiping Xu, Zain Kassam
Severe and severe-complicated Clostridium difficile infection (CDI) is associated with high morbidity and mortality. Colectomy is standard of care; however, post-surgical mortality rates approach 50%. Case reports suggest fecal microbiota transplant (FMT) is a promising treatment of severe and severe-complicated disease but there is a paucity of data. Here, we present a single center experience with a novel sequential FMT protocol for patients refractory to maximal medical therapy. This approach consists of at least one FMT delivered via colonoscopy with criteria for repeat FMT and continued vancomycin therapy based on clinical response and pseudomembranes...
May 4, 2017: Gut Microbes
journal
journal
42248
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"